An overview of Helicobacter pylori infections, diagnostic methods and treatment

被引:0
作者
Mohammadi, Mohammad Reza [1 ]
Omidi, Amir Hossein [2 ]
Mohsenzadeh, Amin [3 ]
Sabati, Hoda [4 ]
Daliri, Layegheh [1 ]
机构
[1] Tarbiat Modares Univ, Fac Med Sci, Dept Bacteriol, Tehran, Tehran, Iran
[2] Pasteur Inst Iran, Res Ctr Emerging & Reemerging Infect Dis, Dept Epidemiol & Biostat, Tehran, Iran
[3] Islamic Azad Univ, Fac Sci, Dept Microbiol, Ardabil Branch, Ardebil, Iran
[4] Shahid Chamran Univ Ahvaz, Fac Sci, Biotechnol & Biol Sci Res Ctr, Ahvaz, Iran
来源
REVIEWS AND RESEARCH IN MEDICAL MICROBIOLOGY | 2024年 / 35卷 / 02期
关键词
amoxicillin; H; pylori; levofloxacin; metronidazole; treatment; VIRULENCE FACTORS; IMMUNE-RESPONSE; ASTHMA; RISK; TRANSMISSION; ERADICATION; PROTEIN; ARTICLE;
D O I
10.1097/MRM.0000000000000353
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: Helicobacter pylori is one of the most common infectious diseases in the world, causing peptic ulcers and gastric cancer in humans. Methods: Here, we used the words 'Helicobacter pylori', 'identification' and 'treatment' from the published data in PubMed, Scopus, and Google Scholar databases for this study. Results: Methods of identification of H. pylori are divided into two categories: invasive and noninvasive. Invasive methods detect bacteria directly from gastric biopsy, but noninvasive methods examine different samples. The key to effective treatment for H. pylori infection is the use of combination therapy, similar to the treatment for bacterial meningitis or endocarditis. Although alternative therapies, including herbal remedies and probiotics, have been used to improve eradication, current treatments still rely on a combination of antimicrobial agents such as amoxicillin, clarithromycin, metronidazole, and levofloxacin, as well as antisecretory agents such as proton pump inhibitors. Conclusion: Both invasive and noninvasive diagnostic methods identify H. pylori. Combination therapies are more efficient in eradicating the bacterium.
引用
收藏
页码:69 / 77
页数:9
相关论文
共 61 条
[1]   Helicobacter pylorivirulence factors expression affect epigenetic factors leading to gastrointestinal carcinoma [J].
Al-Alo, K. Z. K. ;
Al-abodi, Hiba R. ;
Raheem, Lateef Al-Awsi Ghaidaa ;
Alghanimi, Yasemin K. ;
Alshammari, Majida M. M. ;
Mirforughi, Seyede A. .
REVIEWS IN MEDICAL MICROBIOLOGY, 2020, 31 (03) :117-125
[2]   Asthma is inversely associated with Helicobacter pylori status [J].
Arram, Eman O. ;
Shahin, Doaa A. ;
Sherif, Magda M. .
EGYPTIAN JOURNAL OF CHEST DISEASES AND TUBERCULOSIS, 2012, 61 (03) :41-45
[3]  
Atherton JC, 2001, Helicobacter pylori: physiology and genetics
[4]   Mechanisms of the Epithelial-Mesenchymal Transition and Tumor Microenvironment in Helicobacter pylori-Induced Gastric Cancer [J].
Baj, Jacek ;
Korona-Glowniak, Izabela ;
Forma, Alicja ;
Maani, Amr ;
Sitarz, Elzbieta ;
Rahnama-Hezavah, Mansur ;
Radzikowska, Elzbieta ;
Portincasa, Piero .
CELLS, 2020, 9 (04)
[5]   Helicobacter pylori in human health and disease: Mechanisms for local gastric and systemic effects [J].
Bravo, Denisse ;
Hoare, Anilei ;
Soto, Cristopher ;
Valenzuela, Manuel A. ;
Quest, Andrew F. G. .
WORLD JOURNAL OF GASTROENTEROLOGY, 2018, 24 (28) :3071-3089
[6]   Helicobacter pylori infection:: Treatment options [J].
Calvet, X .
DIGESTION, 2006, 73 :119-128
[7]  
Cantón R, 2001, REV MED MICROBIOL, V12, P47
[8]   Accumulated evidence on Helicobacter pylori infection and the risk of asthma A meta-analysis [J].
Chen, Cheng ;
Xun, Pengcheng ;
Tsinovoi, Cari ;
He, Ka .
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2017, 119 (02) :137-+
[9]   A community-based study on the association between Helicobacter pylori Infection and obesity [J].
Chen, Li-Wei ;
Kuo, Sheng-Fong ;
Chen, Chih-Hung ;
Chien, Cheng-Hung ;
Lin, Chih-Lang ;
Chien, Rong-Nan .
SCIENTIFIC REPORTS, 2018, 8
[10]   A systematic approach toward stabilization of CagL, a protein antigen from Helicobacter pylori that is a candidate subunit vaccine [J].
Choudhari, Shyamal P. ;
Pendleton, Kirk P. ;
Ramsey, Joshua D. ;
Blanchard, Thomas G. ;
Picking, William D. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2013, 102 (08) :2508-2519